These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 301781)

  • 21. High-dose methotrexate in acute lymphocytic leukemia.
    Freeman AI; Wang JJ; Sinks LF
    Cancer Treat Rep; 1977 Jul; 61(4):727-31. PubMed ID: 267510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved therapeutic index with high-dose methotrexate: comparison of thymidine-purine rescue with citrovorum factor rescue in mice.
    Samuels LL; Straw JA
    Cancer Res; 1984 Jun; 44(6):2278-84. PubMed ID: 6609764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of hydration on plasma concentrations of methotrexate in patients with osteosarcoma treated with high doses of methotrexate].
    Ferrari S; Orlandi M; Avella M; Caldora P; Ferraro A; Ravazzolo G; Bacci G
    Minerva Med; 1992 May; 83(5):289-93. PubMed ID: 1589134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [High dose methotrexate with leucovorin rescue in the treatment of malignant lymphoma].
    Sampi K; Hattori M
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1068-73. PubMed ID: 6985194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of mycosis fungoides lymphoma: effectiveness of infusions of methotrexate followed by oral citrovorum factor.
    McDonald CJ; Bertino JR
    Cancer Treat Rep; 1978 Jul; 62(7):1009-14. PubMed ID: 308391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-related pharmacokinetics of high-dose methotrexate in patients with osteosarcoma.
    Wang YM; Sutow WW; Romsdahl MM; Perez C
    Cancer Treat Rep; 1979 Mar; 63(3):405-10. PubMed ID: 284845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [l-folinic acid versus racemic folinic acid in the treatment of leukemia in children with high dose of methotrexate].
    Etienne MC; Thyss A; Bertrand Y; Rubie H; Milano G
    Bull Cancer; 1993 Apr; 80(4):357-63. PubMed ID: 8173189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results and pharmacokinetic aspects of methotrexate therapy in high doses].
    Lenzhofer R; Jaschek I; Breyer S; Graninger W; Moser K
    Acta Med Austriaca Suppl; 1979; 6():331-3. PubMed ID: 318045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of methotrexate and sequential methotrexate-5-fluorouracil for patients with recurrent squamous cell carcinoma of the oral cavity.
    Airoldi M; Pedani F; Brando V; Gabriele P; Orecchia R
    Chemioterapia; 1987 Dec; 6(6):390-2. PubMed ID: 3435920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antineoplastic agents: high-dose methotrexate and citrovorum factor rescue.
    Sadée W
    Ther Drug Monit; 1980; 2(2):177-85. PubMed ID: 6762711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience.
    Garrett AP; Garner EO; Goldstein DP; Berkowitz RS
    J Reprod Med; 2002 May; 47(5):355-62. PubMed ID: 12063874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of a massive dosage of methotrexate and leucovorin rescue therapy on acute leukemia and malignant lymphoma].
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):421-32. PubMed ID: 6764106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [High dose methotrexate with CF rescue therapy in patients with head and neck cancer].
    Inuyama Y; Taketa C; Hiroto I; Fujii M; Takaoka T; Tanaka J; Matsuura S; Satake B; Takeoda S; Nishijima W
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1823-31. PubMed ID: 6332576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methotrexate. II. Use in pediatric chemotherapy.
    Lippens RJ
    Am J Pediatr Hematol Oncol; 1984; 6(4):397-413. PubMed ID: 6398630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methotrexate treatment of advanced head and neck cancers: a dose response evaluation.
    Woods RL; Fox RM; Tattersall MH
    Cancer Treat Rep; 1981; 65 Suppl 1():155-9. PubMed ID: 7034929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
    Lange BJ; Blatt J; Sather HN; Meadows AT
    Med Pediatr Oncol; 1996 Jul; 27(1):15-20. PubMed ID: 8614385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose methotrexate for advanced breast cancer.
    Yap HY; Blumenschein GR; Yap BS; Hortobagyi GN; Tashima CK; Wang AY; Benjamin RS; Bodey GP
    Cancer Treat Rep; 1979 May; 63(5):757-61. PubMed ID: 313246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of drug-related deaths secondary to high-dose methotrexate and citrovorum factor administration.
    Von Hoff DD; Penta JS; Helman LJ; Slavik M
    Cancer Treat Rep; 1977 Jul; 61(4):745-8. PubMed ID: 301783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.
    Chi SN; Gardner SL; Levy AS; Knopp EA; Miller DC; Wisoff JH; Weiner HL; Finlay JL
    J Clin Oncol; 2004 Dec; 22(24):4881-7. PubMed ID: 15611503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
    Juergens H; Kosloff C; Nirenberg A; Mehta BM; Huvos AG; Rosen G
    Natl Cancer Inst Monogr; 1981 Apr; (56):221-6. PubMed ID: 6975439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.